This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignee: Amgen Inc.. Active years: 2019-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2022
Title: Asher Lower: Innovator in Pharmaceutical Development
Introduction
Asher Lower is a notable inventor based in Moorpark, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for chronic kidney disease.
Latest Patents
Asher Lower holds 2 patents. His latest patents include a method for preparing AMG 416 (etelcalcetide). This method provides a way to prepare AMG 416, or a pharmaceutically acceptable salt thereof. AMG 416 is a synthetic, eight amino-acid selective peptide agonist of the calcium sensing receptor. It is being developed as an intravenous treatment for secondary hyperparathyroidism (SHPT) in hemodialysis patients with chronic kidney disease-mineral and bone disorder (CKD-MBD).
Career Highlights
Asher Lower is currently associated with Amgen Inc., a leading biotechnology company. His work focuses on innovative solutions to complex medical challenges, particularly in the realm of kidney health.
Collaborations
Asher has collaborated with esteemed colleagues such as Jeroen Bezemer and Ying Chen. Their combined expertise contributes to the advancement of pharmaceutical research and development.
Conclusion
Asher Lower's contributions to the field of pharmaceuticals, particularly through his patents and collaborations, highlight his role as an innovator in medical science. His work continues to pave the way for advancements in treatments for chronic conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile